The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial

Satoru Muto, Haruna Kawano, Eiji Higashihara, Ichiei Narita, Yoshifumi Ubara, Takayuki Matsuzaki, John Ouyang, Vicente E. Torres, Shigeo Horie

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences